• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

提高生物工程骨构建体疗效的策略:一个视角。

Strategies for improving the efficacy of bioengineered bone constructs: a perspective.

机构信息

Laboratoire de Bioingénierie et Biomatériaux Ostéo-Articulaires-UMR CNRS 7052, 10 Avenue de Verdun, 75010 Paris, France.

出版信息

Osteoporos Int. 2011 Jun;22(6):2017-21. doi: 10.1007/s00198-011-1614-1.

DOI:10.1007/s00198-011-1614-1
PMID:21523397
Abstract

Bioengineered bone scaffolds are intended for use in large bone defects. Successful bone constructs should stimulate and support both the onset and the continuance of bone ingrowth. In an attempt to improve their performance and to compete with the one of autologous bone grafts, a growing symbiosis at the biological and material level is required. Recent advances have been made to further exploit the osteogenic potential of MSCs in scaffold development. Current research encompasses new strategies for reducing cell death after implantation and the manufacturing of tailored, instructive scaffolds.

摘要

生物工程骨支架用于治疗大的骨缺损。成功的骨构建物应能刺激和支持骨长入的起始和持续。为了提高其性能并与自体骨移植物竞争,需要在生物学和材料层面上进行不断发展的共生关系。最近的进展已经在支架开发中进一步利用了间充质干细胞的成骨潜能。目前的研究包括减少植入后细胞死亡的新策略和定制、有指导作用的支架的制造。

相似文献

1
Strategies for improving the efficacy of bioengineered bone constructs: a perspective.提高生物工程骨构建体疗效的策略:一个视角。
Osteoporos Int. 2011 Jun;22(6):2017-21. doi: 10.1007/s00198-011-1614-1.
2
Recent Advances in Endocrine, Metabolic and Immune Disorders: Mesenchymal Stem Cells (MSCs) and Engineered Scaffolds.内分泌、代谢及免疫紊乱的最新进展:间充质干细胞(MSCs)与工程支架
Endocr Metab Immune Disord Drug Targets. 2018;18(5):466-469. doi: 10.2174/1871530318666180423102905.
3
Long-bone critical-size defects treated with tissue-engineered grafts: a study on sheep.用组织工程移植物治疗长骨临界尺寸缺损:一项在绵羊身上的研究。
J Orthop Res. 2007 Jun;25(6):741-9. doi: 10.1002/jor.20352.
4
Efficacy of tissue engineered bone grafts containing mesenchymal stromal cells for cleft alveolar osteoplasty in a rat model.含间充质基质细胞的组织工程骨移植物用于大鼠牙槽裂骨成形术的疗效
J Craniomaxillofac Surg. 2014 Oct;42(7):1277-85. doi: 10.1016/j.jcms.2014.03.010. Epub 2014 Apr 4.
5
In Vivo Bone Formation Within Engineered Hydroxyapatite Scaffolds in a Sheep Model.羊模型中工程化羟基磷灰石支架内的体内骨形成
Calcif Tissue Int. 2016 Aug;99(2):209-23. doi: 10.1007/s00223-016-0140-8. Epub 2016 Apr 13.
6
Towards an intraoperative engineering of osteogenic and vasculogenic grafts from the stromal vascular fraction of human adipose tissue.从人脂肪组织基质血管部分构建成骨和血管生成的移植体的术中工程。
Eur Cell Mater. 2010 Mar 3;19:127-35. doi: 10.22203/ecm.v019a13.
7
A concept for scaffold-based tissue engineering in alveolar cleft osteoplasty.牙槽裂骨成形术中基于支架的组织工程概念。
J Craniomaxillofac Surg. 2015 Jul;43(6):830-6. doi: 10.1016/j.jcms.2015.04.023. Epub 2015 May 5.
8
Investigation of a thermoplastic polymeric carrier for bone tissue engineering using allogeneic mesenchymal stem cells in granular scaffolds.使用颗粒状支架中的同种异体间充质干细胞对用于骨组织工程的热塑性聚合物载体进行研究。
J Prosthodont. 2007 Nov-Dec;16(6):421-30. doi: 10.1111/j.1532-849X.2007.00218.x. Epub 2006 Aug 6.
9
Efficient in vivo bone formation by BMP-2 engineered human mesenchymal stem cells encapsulated in a projection stereolithographically fabricated hydrogel scaffold.通过Projection Stereolithography 制造的水凝胶支架包被的 BMP-2 工程化人间充质干细胞促进体内高效成骨。
Stem Cell Res Ther. 2019 Aug 14;10(1):254. doi: 10.1186/s13287-019-1350-6.
10
Mesenchymal stem cells for bone repair: preclinical studies and potential orthopedic applications.用于骨修复的间充质干细胞:临床前研究及潜在的骨科应用
Foot Ankle Clin. 2005 Dec;10(4):651-65, viii. doi: 10.1016/j.fcl.2005.06.004.

引用本文的文献

1
Allogenic Bone Graft Enriched by Periosteal Stem Cell and Growth Factors for Osteogenesis in Critical Size Bone Defect in Rabbit Model: Histopathological and Radiological Evaluation.异体骨移植富含骨膜干细胞和生长因子用于兔模型临界尺寸骨缺损的骨生成:组织病理学和放射学评估
Iran J Pathol. 2020 Summer;15(3):205-216. doi: 10.30699/ijp.2020.101715.2013. Epub 2020 Apr 21.
2
Intrinsic Osteoinductivity of Porous Titanium Scaffold for Bone Tissue Engineering.用于骨组织工程的多孔钛支架的内在骨诱导性
Int J Biomater. 2017;2017:5093063. doi: 10.1155/2017/5093063. Epub 2017 Jul 26.
3
Recent biological trends in management of fracture non-union.

本文引用的文献

1
Survival and function of mesenchymal stem cells (MSCs) depend on glucose to overcome exposure to long-term, severe and continuous hypoxia.间充质干细胞(MSCs)的生存和功能依赖于葡萄糖来克服长期、严重和持续缺氧的影响。
J Cell Mol Med. 2011 Jul;15(7):1505-14. doi: 10.1111/j.1582-4934.2010.01138.x.
2
Overexpressing cellular repressor of E1A-stimulated genes protects mesenchymal stem cells against hypoxia- and serum deprivation-induced apoptosis by activation of PI3K/Akt.过表达细胞 E1A 刺激基因的阻遏物通过激活 PI3K/Akt 保护间充质干细胞免受低氧和血清剥夺诱导的凋亡。
Apoptosis. 2010 Apr;15(4):463-73. doi: 10.1007/s10495-009-0434-7.
3
骨折不愈合治疗的近期生物学趋势
World J Orthop. 2015 Sep 18;6(8):623-8. doi: 10.5312/wjo.v6.i8.623.
4
Osteodifferentiation of human preadipocytes induced by strontium released from hydrogels.水凝胶释放的锶诱导人脂肪前体细胞的骨分化。
Int J Biomater. 2012;2012:865291. doi: 10.1155/2012/865291. Epub 2012 Aug 9.
5
Scaffold-free microtissues: differences from monolayer cultures and their potential in bone tissue engineering.无支架微组织:与单层培养的差异及其在骨组织工程中的潜力。
Clin Oral Investig. 2013 Jan;17(1):9-17. doi: 10.1007/s00784-012-0763-8. Epub 2012 Jun 14.
6
Cell sources for bone tissue engineering: insights from basic science.骨组织工程的细胞来源:基础科学的启示。
Tissue Eng Part B Rev. 2011 Dec;17(6):449-57. doi: 10.1089/ten.TEB.2011.0243. Epub 2011 Sep 27.
Priming integrin alpha5 promotes human mesenchymal stromal cell osteoblast differentiation and osteogenesis.
激活整合素α5可促进人间充质干细胞向成骨细胞分化及骨生成。
Proc Natl Acad Sci U S A. 2009 Nov 3;106(44):18587-91. doi: 10.1073/pnas.0812334106. Epub 2009 Oct 20.
4
Ischemic preconditioning augments survival of stem cells via miR-210 expression by targeting caspase-8-associated protein 2.缺血预处理通过靶向半胱氨酸天冬氨酸蛋白酶 8 相关蛋白 2 增加 miR-210 表达从而增强干细胞的存活。
J Biol Chem. 2009 Nov 27;284(48):33161-8. doi: 10.1074/jbc.M109.020925. Epub 2009 Aug 31.
5
Short-time survival and engraftment of bone marrow stromal cells in an ectopic model of bone regeneration.骨髓基质细胞在异位骨再生模型中的短期存活和植入。
Tissue Eng Part A. 2010 Feb;16(2):489-99. doi: 10.1089/ten.TEA.2009.0041.
6
Fabrication and characterization of prosurvival growth factor releasing, anisotropic scaffolds for enhanced mesenchymal stem cell survival/growth and orientation.用于增强间充质干细胞存活/生长及定向的促存活生长因子释放各向异性支架的制备与表征
Biomacromolecules. 2009 Sep 14;10(9):2609-18. doi: 10.1021/bm900541u.
7
In vitro and in vivo bioluminescent quantification of viable stem cells in engineered constructs.在体外用和体内生物发光定量工程化构建中的活干细胞。
Tissue Eng Part C Methods. 2010 Jun;16(3):447-58. doi: 10.1089/ten.TEC.2009.0004.
8
Lysophosphatidic acid protects mesenchymal stem cells against ischemia-induced apoptosis in vivo.溶血磷脂酸在体内保护间充质干细胞免受缺血诱导的凋亡。
Stem Cells Dev. 2009 Sep;18(7):947-54. doi: 10.1089/scd.2008.0352.
9
Paracrine action of HO-1-modified mesenchymal stem cells mediates cardiac protection and functional improvement.HO-1修饰的间充质干细胞的旁分泌作用介导心脏保护和功能改善。
Cell Biol Int. 2008 Oct;32(10):1256-64. doi: 10.1016/j.cellbi.2008.07.010. Epub 2008 Jul 23.
10
Strategies to promote donor cell survival: combining preconditioning approach with stem cell transplantation.促进供体细胞存活的策略:将预处理方法与干细胞移植相结合。
J Mol Cell Cardiol. 2008 Oct;45(4):554-66. doi: 10.1016/j.yjmcc.2008.05.004. Epub 2008 May 10.